NIP-004

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNIP-004
Drug Alias Nameblood clotting modulator (Nissan)peptidomimetic thrombopoietin agonist (Nissan Chemical)NIP-004
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionThrombopoietin receptor agonists
TargetsThrombopoietin receptor
Therapy Area/IndicationsThrombocytopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNissan Chemical Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNissan Chemical Corp
Active IndicationsN/A
Inactive IndicationsThrombocytopenia

Other Information

ATC CodeN/A
Related LinksN/A